A Novel Use of Spironolactone: Treatment of Hirsutism
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
An excess of androgens is the recognized cause of hirsutism in women. In this study, the antiandrogenic properties of spironolactone were tested clinically in 30 hirsute women. The drug was administered from the 4th to the 22nd day of each menstrual cycle. The moderate side effects in no case forced interruption of the treatment. Hair growth diminished substantially in 23 of the patients, the effect becoming evident 3-5 months after the commencement of treatment. Serum testosterone concentrations decreased in all patients, and estradiol increased in 25 women. Our data suggest that the antiandrogenic properties of spironolactone render it a suitable agent in the treatment of hirsutism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MENARD, R. H., STRIPP, B., & GILLETTE, J. R. (1974) · Endocrinology · doi:10.1210/endo-94-6-1628 · Cited by 117
Cited by
Bioavailability of Albumin-Bound Testosterone†
MANNI, A., M, W., CEFALU, W., NISULA, B. C., BARDIN, C. W., SANTNER, S. J., & SANTEN, R. J. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-4-705 · Cited by 268
The management of patients with polycystic ovary syndrome
Jayasena, C. N., & Franks, S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.102 · Cited by 196
Oral spironolactone: an effective treatment for acne vulgaris in women
MUHLEMANN, M. F., CARTER, G. D., CREAM, J. J., & WISE, P. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb05722.x · Cited by 144
Spironolactone in the treatment of polycystic ovary syndrome
Armanini, D., Andrisani, A., Bordin, L., & Sabbadin, C. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1215430 · Cited by 53
The endocrine effects of spironolactone used as an antiandrogen
Young, R. L., Goldzieher, J. W., & Elkind-Hirsch, K. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59346-7 · Cited by 38
Metadata
- Authors
- SHAPIRO, G., & EVRON, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1980-09
- Volume
- 51
- Issue
- 3
- Pages
- 429-432
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2009498181
- Cited by
- 127
- References
- 1
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Novel Use of Spironolactone: Treatment of Hirsutism. https://app.cochat.ai/papers/10.1210/jcem-51-3-429
- The paper
- SHAPIRO, G., & EVRON, S. (1980). A Novel Use of Spironolactone: Treatment of Hirsutism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-51-3-429
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.